Skip to content

Evaluation of the efficacy and tolerance of a throat spray based on essential oil of Cymbopogon giganteus

Evaluation of the efficacy and tolerance of a throat spray based on essential oil of Cymbopogon giganteus on sore throat at the Hospital and University Center of SURU-LERE area of Cotonou

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10896729
Enrollment
30
Registered
2023-03-11
Start date
2023-02-06
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sore throat Signs and Symptoms

Interventions

Participants will be treated with the traditional plant preparation as mouthwash for 7 days

Sponsors

Ufr Pharmacie/ Faculte des Sciences de la Sante de Cotonou
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Current participant inclusion criteria as of 22/10/2024: 1. 18 to 65 years old 2. Sign the informed consent form 3. Outpatient with sore throat with the 7 clinical signs: Throat pain in the oropharynx Fever, Oropharyngeal redness, Oropharyngeal exudate, Tonsil hypertrophy, Lymphoid formation on the posterior pharyngeal wall, Cervical lymphadenopathy Previous participant inclusion criteria: 1. 18 to 50 years old 2. Sign the informed consent form 3. Outpatient with sore throat with the 7 clinical signs: Throat pain in the oropharynx Fever, Oropharyngeal redness, Oropharyngeal exudate, Tonsil hypertrophy, Lymphoid formation on the posterior pharyngeal wall, Cervical lymphadenopathy

Exclusion criteria

Exclusion criteria: 1. Having ongoing conventional treatment for angina 2. Having a known allergy to one of the constituents of the investigational product 3. Pregnant women 4. People with respiratory problems

Design outcomes

Primary

MeasureTime frame
Clinical signs of sore throat at baseline and 3 days measured by the treating physician: 1. Throat pain at the level of the oropharynx 2. Fever 3. Redness of the oropharynx 4. Oropharyngeal exudate 5. Hypertrophy of the tonsil 6. Lymphoid formation on the pharyngo-posterior wall 7. Cervical adenopathy

Secondary

MeasureTime frame
1. Clinical signs of sore throat at 7 days measured by the treating physician 2. Tolerance of the throat spray measured by patient report at 7 days

Countries

Benin

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026